De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia.
Page 1 of 1
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia.
Gauthier J, Champagne N, Lafrenière RG, Xiong L, Spiegelman D, Brustein E, Lapointe M, Peng H, Côté M, Noreau A, Hamdan FF, Addington AM, Rapoport JL, Delisi LE, Krebs MO, Joober R, Fathalli F, Mouaffak F, Haghighi AP, Néri C, Dubé MP, Samuels ME, Marineau C, Stone EA, Awadalla P, Barker PA, Carbonetto S, Drapeau P, Rouleau GA; the S2D Team. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A. 2010 Apr 12. [Epub ahead of print]
Similar topics
» Identification of mutations in the MYO9A gene in patients with congenital myasthenic syndrome
» Mutations in the Gene That Encodes the F-Actin Binding Protein Anillin Cause FSGS
» Mutations in the SPARC-Related Modular Calcium-Binding Protein 1 Gene, SMOC1, Cause Waardenburg Anophthalmia Syndrome
» Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia
» De novo SOX11 mutations cause Coffin-Siris syndrome
» Mutations in the Gene That Encodes the F-Actin Binding Protein Anillin Cause FSGS
» Mutations in the SPARC-Related Modular Calcium-Binding Protein 1 Gene, SMOC1, Cause Waardenburg Anophthalmia Syndrome
» Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia
» De novo SOX11 mutations cause Coffin-Siris syndrome
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
|
|